Skip to main content
Article
Abstract OT1-04-02: NRG oncology/RTOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain met from HER2-positive breast cancer — A collaborative study of RTOG & KROG (NCT01622868)
Cancer Research (2017)
  • Jr White, Ohio State University
  • J Moughan
  • Ia Kim
  • Dm Peereboom, Cleveland Clinic
  • Jf De Los Santos, University of Alabama at Birmingham
  • Pw Sperduto, University of Minnesota
  • Mp Mehta, University of Maryland, Baltimore
Publication Date
February 15, 2017
DOI
10.1158/1538-7445.SABCS16-OT1-04-02
Citation Information
White, J Moughan, Ia Kim, Dm Peereboom, et al.. "Abstract OT1-04-02: NRG oncology/RTOG 1119: Phase II randomized study of whole brain radiotherapy with concurrent lapatinib in patients with brain met from HER2-positive breast cancer — A collaborative study of RTOG & KROG (NCT01622868)" Cancer Research Vol. 77 (2017)
Available at: http://works.bepress.com/minesh-mehta/27/